13F Holdings
中文EN

ICUI ICU MEDICAL INC/DE

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 883984 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-5.9%
TTM net income YoY919.5%
TTM EPS YoY846.9%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—

Margins

Gross margin40.3%
Operating margin5.1%
Net margin2.8%
FCF margin9.6%
EBITDA margin11.2%

Returns

ROE2.8%
ROA1.5%
ROIC (approx.)3.6%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets44.4%
Debt / equity0.53x
Current ratio2.37x
Interest coverage1.41x

Cash quality & payout

Operating cash flow / net income4.63x
Accruals ratio-5.4%
Payout ratio—
Capex / revenue3.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.23B$2.38B$2.26B$2.28B$1.32B
Cost of revenue$1.41B$1.56B$1.52B$1.58B$824.82M
Gross profit$822.04M$824.78M$739.87M$697.76M$491.49M
R&D expense$87.50M$88.61M$85.34M$92.98M$47.50M
SG&A expense$625.21M$638.76M$606.69M$608.35M$302.58M
Operating income$42.83M$42.96M$22.82M-$42.90M$123.25M
Interest expense$93.34M$106.54M$102.73M$70.81M$858,000
Pretax income$4.36M-$66.01M-$78.30M-$135.65M$81.48M
Income tax$2.44M$51.68M-$48.64M-$40.12M$20.05M
Net income$732,000-$117.69M-$29.66M-$74.29M$103.14M
EBITDA$243.57M$262.48M$251.60M$192.25M$212.94M
EPS (basic)0.03-4.83-1.23-3.114.86
EPS (diluted)0.03-4.83-1.23-3.114.74
Weighted avg. shares (diluted)24.90M24.39M24.09M23.87M21.78M
Banking
Net interest income-$83.03M-$95.75M-$95.22M-$66.38M$1.98M
Balance sheet
Cash & equivalents$307.96M$308.57M$254.22M$208.78M$552.83M
Short-term investments—$0$501,000$4.22M$14.42M
Receivables$180.51M$182.83M$161.57M$221.72M$105.89M
Inventory$615.86M$584.68M$709.36M$696.01M$290.24M
Current assets$1.19B$1.44B$1.22B$1.24B$1.03B
PP&E, net$451.82M$442.75M$612.91M$636.11M$468.37M
Goodwill$1.50B$1.43B$1.47B$1.45B$43.44M
Intangibles$633.56M$740.79M$870.59M$982.77M$188.31M
Total assets$4.05B$4.20B$4.38B$4.52B$1.88B
Current liabilities$498.86M$556.18M$481.84M$494.56M$200.78M
Short-term debt$18.75M$51.00M$51.00M$29.69M$0
Long-term debt$1.27B$1.53B$1.58B$1.62B$0
Total debt$1.28B$1.58B$1.63B$1.65B$0
Total liabilities$1.93B$2.24B$2.26B$2.43B$264.71M
Shareholders' equity$2.12B$1.97B$2.12B$2.09B$1.62B
Net debt$976.70M$1.27B$1.37B$1.44B-$552.83M
Shares outstanding24.69M24.52M24.14M23.99M21.28M
Cash flow statement
Operating cash flow$179.85M$204.03M$166.20M-$62.13M$267.54M
Capital expenditure$88.04M$79.37M$83.89M$90.31M$68.54M
Free cash flow$91.80M$124.66M$82.31M-$152.44M$199.00M
Investing cash flow$122.23M-$88.96M-$87.95M-$1.91B-$90.69M
Financing cash flow-$311.52M-$55.80M-$35.98M$1.64B-$16.87M
Depreciation & amortization$200.74M$219.51M$228.77M$235.15M$89.70M
Stock-based compensation$55.76M$46.88M$40.56M$36.02M$27.34M
Share buybacks$8.77M$11.99M$9.35M$10.88M$8.34M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.